Fundz

Trogenix Appoints Atif Abbas as Chief Medical Officer

PRIVATEJul 18, 2025

Company

Trogenix

EdinburghBiotechnologyHealth Care

Description

Trogenix announces the appointment of Atif Abbas as Chief Medical Officer, enhancing its clinical research team. With over 25 years of experience in oncology drug development, Atif will lead clinical excellence as the company advances its R&D pipeline.

Quick answer

Trogenix Appoints Atif Abbas as Chief Medical Officer (July 18, 2025). Trogenix is based in Edinburgh, Scotland, United Kingdom.

What did Trogenix announce on July 18, 2025?
Trogenix announces the appointment of Atif Abbas as Chief Medical Officer, enhancing its clinical research team. With over 25 years of experience in oncology drug development, Atif will lead clinical excellence as the company advances its R&D pipeline.
What does Trogenix do?
Trogenix stands at the forefront of cancer therapy innovation, uniting cutting-edge technologies in genomics, synthetic biology, sophisticated oncology disease models, advanced gene therapy systems, and immunotherapy...
Where is Trogenix based?
Trogenix is based in Edinburgh, Scotland, United Kingdom.
Which similar companies made leadership changes around the same time?
Champions Oncology (July 18, 2025), PolyActiva (July 17, 2025), Exactech (July 17, 2025) and Propel Health (July 17, 2025) also announced leadership changes within 45 days of Trogenix.

Source: Fundz verified event record.

Other recent leadership changes in Biotechnology and Health Care

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Trogenix, and when

A new leader at Trogenix brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Trogenix raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Trogenix, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Trogenix. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Trogenix

Location

Edinburgh, Scotland, United Kingdom

About

Trogenix stands at the forefront of cancer therapy innovation, uniting cutting-edge technologies in genomics, synthetic biology, sophisticated oncology disease models, advanced gene therapy systems, and immunotherapy expertise.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Trogenix changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ken
Likely contact at this company
••••••••@••••••••

See Ken's verified email →

Bryn
Likely contact at this company
••••••••@••••••••

See Bryn's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Trogenix's next move

Learn about Strategic plan

Trogenix changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.